NCT01730664View on ClinicalTrials.gov

PK/PD of Ertapenem In Patients With TB

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 26, 2017

Primary Completion Date

July 13, 2017

Study Completion Date

July 13, 2017

Conditions
PK of Ertapenem in TB Patients
Interventions
DRUG

ertapenem

single dose of 2000mg ertapenem IV

Trial Locations (1)

Unknown

UMCG - Tuberculosis Center, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01730664 - PK/PD of Ertapenem In Patients With TB | Biotech Hunter | Biotech Hunter